Multimodal tract-based analysis in ALS patients at 7T: A specific white matter profile?

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 15, Issue 1-2, 2014, Pages 84-92

  Verstraete, Esther ^a   Polders, Daniel L ^a   Mandl, René C W ^b   Van Den Heuvel, Martijn P ^b   Veldink, Jan H ^a   Luijten, Peter ^a   Van Den Berg, Leonard H ^a   Hoogduin, Johannes ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Amyotrophic lateral sclerosis; Diffusion tensor imaging; DTI

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN MAPPING; BRAIN SIZE; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; FEMALE; FRACTIONAL ANISOTROPY; HISTOGRAM; HUMAN; MAGNETIZATION TRANSFER RATIO; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROTON TRANSPORT; PYRAMIDAL TRACT; SIGNAL TRANSDUCTION; WHITE MATTER; WHOLE BODY MRI;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANISOTROPY; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEUKOENCEPHALOPATHIES; MALE; MIDDLE AGED; NERVE FIBERS, MYELINATED; PROTONS; PYRAMIDAL TRACTS;

EID: 84895545765     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2013.844168     Document Type: Article

References (48)

1. Smith MC. Nerve Fibre Degeneration in the Brain in Amyotrophic Lateral Sclerosis. J Neurol Neurosurg Psychiatry. 1960;23:269-82.
2. Turner MR, Agosta F, Bede P, Govind V, Lule D, Verstraete E. Neuroimaging in amyotrophic lateral sclerosis. Biomark Med. 2012;6:319-37.
3. Filippini N, Douaud G, Mackay CE, Knight S, Talbot K, Turner MR. Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis. Neurology. 2010; 75:1645-52.
4. Agosta F, Pagani E, Petrolini M, Caputo D, Perini M, Prelle A, et al. Assessment of white matter tract damage in patients with amyotrophic lateral sclerosis: a diffusion tensor MR imaging tractography study. AJNR Am J Neuroradiol. 2010;31:1457-61.
5. Verstraete E, van den Heuvel MP, Veldink JH, Blanken N, Mandl RC, Hulshoff Pol HE, et al. Motor network degeneration in amyotrophic lateral sclerosis: a structural and functional connectivity study. PLoS One. 2010;5: e13664.
6. Beaulieu C. The basis of anisotropic water diffusion in the nervous system: a technical review. NMR in Biomedicine. 2002;15:435-55. (Pubitemid 36054508)
7. Acosta-Cabronero J, Williams GB, Pengas G, Nestor PJ. Absolute diffusivities define the landscape of white matter degeneration in Alzheimer's disease. Brain. 2010;133: 529-39.
8. Glasser MF, van Essen DC. Mapping human cortical areas in vivo based on myelin content as revealed by T1- and T2-weighted MRI. J Neurosci. 2011;31:11597-616.
9. Paus T, Collins DL, Evans AC, Leonard G, Pike B, Zijdenbos A. Maturation of white matter in the human brain: a review of magnetic resonance studies. Brain Res Bull. 2001;54: 255-66. (Pubitemid 32273618)
10. Barkovich AJ. Magnetic resonance techniques in the assessment of myelin and myelination. J Inherit Metab Dis. 2005;28:311-43. (Pubitemid 40723867)
11. Henkelman RM, Stanisz GJ, Graham SJ. Magnetization transfer in MRI: a review. NMR Biomed. 2001;14:57-64. (Pubitemid 32401348)
12. Moll NM, Rietsch AM, Thomas S, Ransohoff AJ, Lee JC, Fox R, et al. Multiple sclerosis normal-appearing white matter: pathology-imaging correlations. Ann Neurol. 2011; 70:764-73.
13. Dula AN, Asche EM, Landman BA, Welch EB, Pawate S, Sriram S, et al. Development of chemical exchange saturation transfer at 7T. Magn Reson Med. 2011;66:831-8.
14. Mougin OE, Coxon RC, Pitiot A, Gowland PA. Magnetization transfer phenomenon in the human brain at 7T. Neuroimage. 2010;49:272-81.
15. Verstraete E, Veldink JH, Mandl RC, van den Berg LH, van den Heuvel MP. Impaired structural motor connectome in amyotrophic lateral sclerosis. PLoS One. 2011;6: e24239.
16. Polders DL, Leemans A, Hendrikse J, Donahue MJ, Luijten PR, Hoogduin JM. Signal to noise ratio and uncertainty in diffusion tensor imaging at 1.5, 3.0, and 7.0 Tesla. J Magn Reson Imaging. 2011;33:1456-63.
17. Leemans A, Jones DK. The B-matrix must be rotated when correcting for subject motion in DTI data. Magn Reson Med. 2009;61:1336-49.
18. Chang LC, Jones DK, Pierpaoli C. RESTORE: robust estimation of tensors by outlier rejection. Magn Reson Med. 2005;53:1088-95. (Pubitemid 40627784)
19. Basser PJ, Pajevic S, Pierpaoli C, Duda J, Aldroubi A. In vivo fibre tractography using DT-MRI data. Magn Reson Med. 2000;44:625-32.
20. Ordidge RJ, Gibbs P, Chapman B, Stehling MK, Mansfield P. High-speed multislice T1 mapping using inversion-recovery echo-planar imaging. Magn Reson Med. 1990; 16:238-45.
21. Clare S, Jezzard P. Rapid T(1) mapping using multislice echo planar imaging. Magn Reson Med. 2001;45:630-4. (Pubitemid 32260085)
22. Polders DL, Leemans A, Luijten PR, Hoogduin H. Uncertainty estimations for quantitative in vivo MRI T1 mapping. J Magn Reson. 2012;224:53-60.
23. Deoni SC. Quantitative relaxometry of the brain. Top Magn Reson Imaging. 2010;21:101-13.
24. Jones CK, Polders D, Hua J, Zhu H, Hoogduin HJ, Zhou J, et al. In vivo three-dimensional whole-brain pulsed steady-state chemical exchange saturation transfer at 7T. Magn Reson Med. 2012;67:1579-89.
25. Tofts PS, Steens CA, van Buchem MA. Quantitative MRI of the Brain: Measuring Changes Caused by Disease.2003;258-98.
26. van Zijl PC, Yadav NN. Chemical exchange saturation transfer (CEST): what is in a name and what isn't? Magn Reson Med. 2011;65:927-48.
27. Zhou J, Payen JF, Wilson DA, Traystman RJ, van Zijl PC. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med. 2003; 9:1085-90. (Pubitemid 37021791)
28. Polders DL, Hoogduin JM. Chemical Exchange Saturation Transfer MR Imaging: Potential Clinical Applications. PET Clinics. 2013; in press.
29. Mandl RC, Schnack HG, Luigjes J, van den Heuvel MP, CahnW, Kahn RS, et al.Tract-based Analysis of Magnetization Transfer Ratio and Diffusion Tensor Imaging of the Frontal and Frontotemporal Connections in Schizophrenia. Schizophr Bull. 2010;36:778-87.
30. van der Graaff MM, Sage CA, Caan MW, Akkerman EM, Lavini C, Majoie CB, et al. Upper and extramotor neuron involvement in early motor neuron disease: a diffusion tensor imaging study. Brain. 2011;134:1211-28.
31. Cosottini M, Pesaresi I, Piazza S, Diciotti S, Cecchi P, Fabbri S, et al. Structural and functional evaluation of cortical motor areas in amyotrophic lateral sclerosis. Exp Neurol. 2012;234:169-80.
32. Agosta F, Pagani E, Rocca MA, Caputo D, Perini M, Salvi F, et al. Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Hum Brain Mapp. 2007; 28:1430-8. (Pubitemid 350237659)
33. Kassubek J, Unrath A, Huppertz HJ, Lule D, Ethofer T, Sperfeld AD, et al. Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel-based morphometry of 3-D MRI. Amyotroph Lateral Scler. 2005; 6:213-20.
34. Chen Z, Ma L. Grey matter volume changes over the whole brain in amyotrophic lateral sclerosis: a voxel-wise meta-analysis of voxel based morphometry studies. Amyotroph Lateral Scler. 2010;11:549-54.
35. Stanisz GJ, Kecojevic A, Bronskill MJ, Henkelman RM. Characterizing white matter with magnetization transfer and T(2). Magn Reson Med. 1999;42:1128-36.
36. Kato Y, Matsumura K, Kinosada Y, Narita Y, Kuzuhara S, Nakagawa T. Detection of pyramidal tract lesions in amyotrophic lateral sclerosis with magnetization-transfer measurements. AJNR Am J Neuroradiol. 1997;18:1541-7. (Pubitemid 30413971)
37. Tanabe JL, Vermathen M, Miller R, Gelinas D, Weiner MW, Rooney WD. Reduced MTR in the corticospinal tract and normal T2 in amyotrophic lateral sclerosis. Magn Reson Imaging. 1998;16:1163-9. (Pubitemid 29019540)
38. da Rocha AJ, Maia AC Jr, Valerio BC. Corticospinal tract MR signal-intensity pseudonormalization on magnetization transfer contrast imaging: a potential pitfall in the interpretation of the advanced compromise of upper motor neurons in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol. 2012;33:79-80.
39. Iwanaga K, Hayashi S, Oyake M, Horikawa Y, Hayashi T, Wakabayashi M, et al. Neuropathology of sporadic amyotrophic lateral sclerosis of long duration. J Neurol Sci. 1997;146:139-43. (Pubitemid 27112833)
40. Ikeda K, Akiyama H, Arai T, Ueno H, Tsuchiya K, Kosaka K. Morphometrical reappraisal of motor neuron system of Pick's disease and amyotrophic lateral sclerosis with dementia. Acta Neuropathol. 2002;104:21-8. (Pubitemid 36075355)
41. Hughes JT. Pathology of amyotrophic lateral sclerosis. Adv Neurol. 1982;36:61-74.
42. Philips T, Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol. 2011;10:253-63.
43. Ince PG, Highley JR, Kirby J, Wharton SB, Takahashi H, Strong MJ, et al. Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology. Acta Neuropathol. 2011;122:657-71.
44. da Rocha AJ, Oliveira AS, Fonseca RB, Maia AC Jr, Buainain RP, Lederman HM. Detection of corticospinal tract compromise in amyotrophic lateral sclerosis with brain MR imaging: relevance of the T1-weighted spin-echo magnetization transfer contrast sequence. AJNR Am J Neuroradiol. 2004;25:1509-15. (Pubitemid 44383601)
45. Carrara G, Carapelli C, Venturi F, Ferraris MM, Lequio L, Chio A, et al. A distinct MR imaging phenotype in amyotrophic lateral sclerosis: correlation between T1 magnetization transfer contrast hyperintensity along the corticospinal tract and diffusion tensor imaging analysis. AJNR Am J Neuroradiol. 2012;33:733-9.
46. Fatouros PP, Marmarou A. Use of magnetic resonance imaging for in vivo measurements of water content in human brain: method and normal values. J Neurosurg. 1999;90: 109-15. (Pubitemid 29024747)
47. Neema M, Stankiewicz J, Arora A, Dandamudi VS, Batt CE, Guss ZD, et al. T1- and T2-based MRI measures of diffuse grey matter and white matter damage in patients with multiple sclerosis. J Neuroimaging. 2007;17 (Suppl 1): S16-21.
48. Vrenken H, Geurts JJ, Knol DL, van Dijk LN, Dattola V, Jasperse B, et al. Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing grey and white matter. Radiology. 2006;240:811-20. (Pubitemid 44267339)